logo
Plus   Neg
Share
Email
Comment

BTG Plc Reiterates FY Product Sales Guidance; Acquires Roxwood Medical

BTG plc (BTG.L) reported that it has delivered a good performance in the first half of the year, with double-digit CER product sales growth. The Group reiterated its product sales guidance for the full year. Specialty Pharmaceuticals is expected to grow by low-to-mid single digits at CER, weighted as expected to the first half. Interventional Medicine is expected to deliver mid-to-high teens growth at CER, with higher growth in the second half.

The Group said licensing revenue in the first half has benefitted from back-royalties on Lemtrada and is now expected to decline over the full year by low double digits at CER versus the original guidance of a high-teens decline.

Separately, BTG plc announced it has acquired Roxwood Medical, a provider of advanced cardiovascular specialty catheters used in the treatment of patients with severe coronary and peripheral artery disease. BTG will pay up to $80 million in cash to acquire Roxwood, comprising $65 million paid on closing and up to an additional $15 million should certain future commercial milestones be achieved. The Group expects the transaction to be accretive to adjusted EPS from the second full year of ownership.

Roxwood's anchoring catheters (CenterCross, CenterCross Ultra, MultiCross) and microcatheters (MicroCross) offer options for physicians in the crossing of complex lesions and arterial blockages.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Cannae Holdings, Inc. said Wednesday that its portfolio company, Ceridian HCM Holding Inc., has confidentially filed for an initial public offering. Ceridian HCM, a provider of human resources software and services, filed a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission relating to the proposed IPO of its common stock. Goldman Sachs Group Inc. on Wednesday reported a loss for the fourth quarter, reflecting lower trading revenue in fixed income, currencies and commodities as well as a charge related to the recent U.S. tax reform. However, both adjusted earnings per share and revenues for the quarter topped analysts' expectations. Bank of America Corp. (BAC) reported a profit for the fourth-quarter of 2017 that declined about 50 percent from last year, hurt by a charge of $2.9 billion or $0.27 per share, related to the Tax Cuts and Jobs Act.
comments powered by Disqus
Follow RTT